High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms
Clinical trial NCT00403546 · COMPLETED
Trial details
- NCT number
- NCT00403546
- Sponsor
- Donald C. Goff, MD
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2011-05-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.